jRCT2031230117
Untitled Trial
A multi center, randomized, double blind, parallel group, phase III study to evaluate efficacy, safety and immunogenicity of Lupins Denosumab in comparison with Prolia in postmenopausal women with osteoporosis.
ID Pharma Co., Ltd.·Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Osteoporosis
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- ID Pharma Co., Ltd.
- Location
- India
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Osteoporosis, unspecifiedOther osteoporosisIdiopathic osteoporosisOsteoporosis in diseases classified elsewherePostmenopausal osteoporosis
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2031230117
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2031230117 through Pure Global AI's free database. This phase not specified trial is sponsored by ID Pharma Co., Ltd. and is currently Recruiting. The study focuses on Osteoporosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.